California AB1843 mandates health insurers and health care service plans to cover direct-acting antiviral drugs for hepatitis C without prior.

California AB1843 amends the Health and Safety Code and the Insurance Code to ensure that health insurers and health care service plans cover direct-acting antiviral drugs for hepatitis C without prior authorization, except under specific conditions. The bill also mandates that clinical criteria for hepatitis C treatment align with guidelines from the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America, or other recognized clinical hepatology or infectious disease associations.

California AB1843 mandates health insurers and health care service plans to cover direct-acting antiviral drugs for hepatitis C without prior.

California AB1843 amends the Health and Safety Code and the Insurance Code to ensure that health insurers and health care service plans cover direct-acting antiviral drugs for hepatitis C without prior authorization, except under specific conditions. The bill also mandates that clinical criteria for hepatitis C treatment align with guidelines from the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America, or other recognized clinical hepatology or infectious disease associations.